PRKD2 Promotes Progression and Chemoresistance of AML via Regulating Notch1 Pathway
Qian Liu,1,2 Wei Li,1 Ying Zhou,1 Jimo Jian,1,3 Shijie Han,4 Chao Liu,5 Wei Li,1 Xunxun Zhu,6 Daoxin Ma,1,7 Min Ji,1 Chunyan Ji1 1Department of Hematology, Qilu Hospital, Shandong University, Jinan 250012, People’s Republic of China; 2Department of Pain, Qilu Hospital, Shandong University,...
Main Authors: | Liu Q, Li W, Zhou Y, Jian J, Han S, Liu C, Zhu X, Ma D, Ji M, Ji C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-12-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/prkd2-promotes-progression-and-chemoresistance-of-aml-via-regulating-n-peer-reviewed-article-OTT |
Similar Items
-
TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1
by: Yihua Pang, et al.
Published: (2020-08-01) -
Targeting IFN-γ-inducible lysosomal thiol reductase overcomes chemoresistance in AML through regulating the ROS-mediated mitochondrial damage
by: Li-Ting Niu, et al.
Published: (2021-09-01) -
Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: towards precision medicine overcoming drug resistance
by: May Levin, et al.
Published: (2021-01-01) -
Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling
by: Wenchu Wang, et al.
Published: (2017-03-01) -
Notch1 is required for hypoxia-induced proliferation, invasion and chemoresistance of T-cell acute lymphoblastic leukemia cells
by: Zou Jie, et al.
Published: (2013-01-01)